1. Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial. (19th March 2019) Authors: Egle, Alexander; Melchardt, Thomas; Obrtlíková, Petra; Smolej, Lukáš; Kozák, Tomáš; Steurer, Michael; Andel, Johannes; Burgstaller, Sonja; Mikušková, Eva; Gercheva, Liana; Nösslinger, Thomas; Papajík, Tomáš; Ladická, Miriam; Girschikofsky, Michael; Hrubiško, Mikuláš; Jäger, Ulrich; Voskova, Danie... Journal: Cancer medicine Issue: Volume 8:Number 4(2019:Apr.) Page Start: 1401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗